Overview
- Pediatrix reported EPS of $0.838 versus $0.46 expected and adjusted EBITDA of $87 million for Q3 2025.
- Pediatrix guided full-year adjusted EBITDA to $270 million–$290 million, cited practice-bonus timing as the key swing factor, and ended the quarter with $340 million in cash and net leverage just under 1x.
- Pediatrix repurchased 1.2 million shares in the quarter, bringing year-to-date buybacks to 1.7 million, and completed targeted practice additions in NICU, MFM and OB hospitalist services.
- AG Mortgage Investment Trust posted EAD of $0.23 per share, increased book value to $10.46, and grew its investment portfolio 21% to $8.8 billion with economic leverage at roughly 1.7 turns.
- MITT rotated roughly $66 million of equity out of legacy WMC positions, completed four securitizations across agency-eligible investor and home-equity loans, increased its Arc Home stake to 66%, and expects about $30 million tied to legacy CRE/hospitality loans to return in the first half of 2026.